L'Amy America and Grosfilley Form Long-Term Partnership for N.A. Distribution, Global Growth

Published on January 26, 2026
NEW YORK—L’Amy America has announced a long-term strategic partnership with Grosfilley, a French eyewear manufacturer with more than 60 years of experience in high-end product development and luxury brand management. This partnership represents a significant milestone for both organizations and extends beyond a traditional licensing or distribution agreement to form a collaborative, long-term commitment that focuses on shared growth, brand development and global expansion, the two companies said in an announcement. The agreement establishes L’Amy America as the North American distribution partner for Grosfilley eyewear brands, including Lancel and Charriol, while also creating reciprocal opportunities for L’Amy’s brands and collaboration within the French and European markets, L’Amy said.
Continue reading on website
Other news

FDA Approves Single-Patient Compassionate Use of Urcosimod for the Treatment of Neuropathic Corneal Pain

January 26, 2026
LONDON and NEW YORK—OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, announced that the U.S. Food and Drug Administration (FDA) has authorized a single-patient expanded access (compassionate use) investigational new drug (IND) for the use of urco

The Vision Council, Independent Optometric Alliance Groups Advocate on Capitol Hill for Affordable Vision Care Policies

January 26, 2026
ALEXANDRIA, Va.—Representatives from The Vision Council, the national trade association representing manufacturers, suppliers, and retailers in the optical industry, joined independent optometric alliance groups and eyewear manufacturers to advocate on Capitol Hill for policies that support affordable vision care, according to an announcement from The Vision Council. Together, they presented a uni